Basic Information
GOOFICE FILM-COATED TABLET 5MG
TABLET, FILM COATED
Regulatory Information
SIN16878P
October 2, 2023
Prescription Only
Therapeutic
ORAL
January 24, 2024
May 30, 2025
Company Information
Active Ingredients
Elobixibat monohydrate eqv elobixibat
Strength: 5 mg
Detailed Information
Contraindications
**4.3 Contraindications** (1) Patients with medical history of hypersensitivity to the ingredients of GOOFICE®. (2) Patients with a documented intestinal obstruction associated with a tumor or hernia or with the suspicion of such conditions. \[Intestinal obstruction may be aggravated.\]
Indication Information
**4.1 Therapeutic indications** GOOFICE® is indicated for the treatment of chronic idiopathic constipation in adults.